Tag Archives: undefined

5 Portfolio Moves For The Second Half

After a relatively calm few months, market volatility is back. In recent weeks, stocks have swung between ups and downs, as investors have attempted to digest the latest news out of Greece , the recent bear market in China and the growing likelihood that the Federal Reserve (Fed) will hold off on raising rates until after its September meeting. Some of this shouldn’t come as a surprise. At BlackRock, we have long been saying that the second half was likely to be characterized by more volatility, given increasing investor attention on the Fed’s next move. We also have long viewed China’s market as expensive. However, not everything has played to script, like some of the twists in Greece’s debt crisis and the possible delay of a Fed rate hike. That said, the big-picture economic themes we discussed in the beginning of the year still appear to be in place: slow but steady growth, low inflation and low rates. Even recent events in Greece and China aren’t likely to have a longer-term impact on the global economy or markets. Against this economic backdrop, we’re sticking with our basic market views. So, to help prepare your portfolio for the second half, investors can consider these five portfolio moves, as I write in the Mid-Year Update to The BlackRock List: What to Know and What to Do in 2015 . Favor stocks over bonds Stocks in general still look more attractively valued than bonds, but certain stock segments offer more value than others. We like international stocks over U.S. ones (more on that in the next bullet point). Meanwhile, within the U.S., we’re cautious on segments that will likely be most affected when interest rates go up, such as utilities. Greater value can be found in sectors positioned to benefit from economic growth, such as technology and financials. Consider more international equity exposure With the U.S. in the sixth year of a bull market, better value exists overseas, particularly in Europe and Japan. While it’s true that Europe is no longer cheap and faces political challenges, contagion from the situation in Greece is unlikely, and we still expect European equities to notch decent performance relative to pricier U.S. stocks. Europe and Japan should also continue to benefit from market-friendly central bank easing, while the U.S. is poised to raise rates soon. Within bonds, favor credit over duration. While bonds remain expensive, it’s important to have some exposure to fixed income. Given that rate volatility will likely remain elevated in coming months, investors may want to look to the high yield sector, which is typically less sensitive to rate movements than other fixed income sectors. We also like tax-exempt municipal bonds, which currently offer attractive yields. Look for tactical opportunities within fixed income Income seekers must keep in mind that rates around most of the world will remain low for some time despite any Fed action, so flexibility and selectivity are critical in fixed income asset allocation. Consider alternatives, but remain cautious on commodities Finally, in a slow-growth world where many traditional assets look pricey, you may want to consider casting a wider net toward alternative investments in an effort to optimize your portfolio’s results. Nontraditional asset classes such as infrastructure or real estate may be worth considering. Commodities, on the other hand, are likely to remain challenged, particularly if real rates continue to rise. The bottom line: As volatility continues, resist the temptation to abandon the markets. A better strategy for long-term investors would typically be to stay the course, assuming your portfolio is aligned properly. Source: BlackRock Original Post

Chesapeake Utilities: A Big Dividend Isn’t Necessary With Earnings Growth Like This

Summary Natural gas and electric utility Chesapeake Utilities has generated impressive historical earnings growth by focusing on capital investments at the expense of dividend payouts. This strategy is set to continue driving earnings growth, as the company invests in high-demand regulated operations and its strong Florida service areas. Florida’s economic and population growth will provide long-term support for the company’s earnings, while cold winter weather in the state will help in the short term. The company’s shares are overvalued at present, but have demonstrated substantial price volatility. Potential investors are advised to watch for a dip that creates a more attractive purchase opportunity. There aren’t many names in the utilities sector that have outperformed the S&P 500 since the start of 2011 by as much as natural gas and electricity distributor Chesapeake Utilities (NYSE: CPK ). Then again, not many utilities firms have increased their annual EPS by 30% over the same period (see figure). Chesapeake has managed to achieve substantial earnings growth in a normally slow-growth sector by investing heavily in its regulated services and identifying high-margin unregulated but related areas to operate within. Historical growth rates are no guarantee of future earnings, however, and it is fair to ask whether the company will be able to continue growing at its recent pace. This article evaluates CPK as a potential long investment opportunity. CPK data by YCharts Chesapeake Utilities at a glance Chesapeake Utilities is a Delaware-based public utility that distributes natural gas, propane, and electricity in multiple service areas on the Eastern Seaboard. It conducts its operations via five regulated wholly-owned subsidiaries and four unregulated wholly-owned subsidiaries. Of the regulated subsidiaries, Chesapeake Utilities is the oldest, and it distributes natural gas to 58,000 residential, commercial, and industrial customers in Delaware and Maryland. Sandpiper Energy distributes natural gas and propane to 11,000 residential and commercial customers in Maryland. Florida Public Utilities deals with multiple types of energy resources, distributing natural gas to 73,000 residential, commercial, and industrial customers throughout the state, electricity to 31,000 customers in north Florida, and propane to 16,000 Florida customers. The subsidiary has achieved rapid customer growth over the last 15 years, as the state’s population has increased by more than 23%. Finally, the last two regulated subsidiaries, Eastern Shore Natural Gas and Peninsula Pipeline, are engaged in the transportation and delivery of natural gas – the former in Delaware, Maryland, and Pennsylvania, and the latter in Florida. The first of Chesapeake Utilities’ unregulated subsidiaries is Sharp Energy, which distributes propane to 37,000 residential, commercial, and industrial customers in Maryland and Pennsylvania. Xeron markets natural gas liquids across the U.S., while PESCO markets natural gas in Delaware, Maryland, and Florida. Grove Energy conducts CNG conversion services in Florida. Finally, Aspire Energy, which was acquired earlier this year for $52.8 million in cash and shares as Gatherco before being renamed, conducts midstream natural gas gathering, processing, transportation, and marketing services in Ohio. Chesapeake sold its IT services subsidiary BravePoint last year, and now only engages in energy and energy-related operations. The company has benefited from a combination of favorable regulatory schemes, as well as growing populations and economies in its service areas over the last several years. These advantages have enabled it to report record earnings in the last eight consecutive years, as its annual EPS has increased at an 11.6% CAGR since FY 2010. The company’s ability to generate high ROEs, with annual ROEs of 11.6% from FY 2010 to FY 2012 and 12.2% since FY 2013, has also contributed to this earnings growth. Earnings growth has in turn led to steady, if underwhelming, dividend growth of 23% (or 5.5% CAGR) since FY 2010. The dividend growth rate has sped up recently, however, achieving 6.5% in FY 2015. The current annual dividend of $1.15/share equates to a modest forward yield of 2.1% at the time of writing. While this low yield is due in part to the company’s impressive share price performance since FY 2010, it also reflects the fact that Chesapeake maintains a low dividend payout ratio (see figure). While disappointing to dividend investors, the relative lack of dividend payments has enabled the company to increase its capex by 108% over the same period. CPK Dividend Yield (TTM) data by YCharts Q1 earnings report Chesapeake Utilities reported impressive Q1 earnings back in May that beat on both lines . The company’s revenue came in at $170 million, down 8.8% YoY from $186.3 million, but beating the consensus estimate by $8.3 million. Revenue from the regulated segment increased by 7.3% versus the previous year to $109.6 million, due primarily to customer growth and an increase to its Florida rate base. The unregulated segment’s revenue fell sharply by 24% to $60.5 million, as the average price of propane during the quarter fell by 59% compared to the previous year. Lower energy prices more broadly caused the company’s cost of revenue during the quarter to fall by 20% YoY, allowing operating income to increase by 19% over the same period. The regulated segment’s operating income increased by $1.1 million, which the company attributed to the Florida rate base increase, customer growth, and the cold weather during the quarter. The unregulated segment’s operating income increased by $4.4 million, driven by the cold weather – with the average temperature being 14% colder than normal – as well as the presence of strong propane retail margins during the quarter. Retail fuel margins were strong across energy sectors, and the propane market was no different. Net income rose to $21.1 million YoY from $17.7 million (see table), resulting in EPS of $1.44 versus $1.22 the previous year, which beat the consensus by $0.28. Both the YoY increase and the beat were primarily attributable to the strong retail propane margins, which boosted EPS by $0.21. Service expansions and natural gas demand growth – the former resulting from the company’s previous capex, and the latter resulting from population growth in its service areas and the cold winter – contributed another $0.10 to EPS. Higher labor and maintenance costs offset these increases by $0.09. Chesapeake Utilities Financials (non-adjusted) Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Revenue ($MM) 170.1 120.4 91.6 100.5 186.3 Gross income ($MM) 77.7 57.0 45.6 47.4 70.7 Net income ($MM) 21.1 10.1 3.2 5.1 17.7 Diluted EPS ($) 1.44 0.69 0.22 0.35 1.22 EBITDA ($MM) 46.3 26.9 16.2 19.3 40.0 Source: Morningstar (2015) Chesapeake Utilities announced multiple investments that were underway during Q1. First, it closed on the Gatherco acquisition – an investment that it expects to be accretive to earnings during the current fiscal year. Management stated that Gatherco was primarily limited before the acquisition by a lack of capital, and is therefore optimistic that it could, in turn, result in additional future earnings growth. The company is also constructing a 20 MW natural gas CHP system in Florida for a total cost of $40 million, and it has already started to sign long-term contracts for the facility’s outputs. Finally, the company is also investing $30 million in new natural gas transmission service infrastructure in its Mid-Atlantic service area to meet additional demand from existing customers. Outlook Chesapeake Utilities is continuing to invest heavily in both its existing infrastructure as well as new capacity. Management expects capex to rise to $223.4 million in FY 2015, compared to the annual average of $94.8 million over the previous three years. These investments will be financed via a combination of debt and equity so as to maintain the company’s existing debt-to-equity ratio. With only $16.2 million in cash on hand at the end of the quarter, this additional financing will be necessary. That said, its balance sheet has plenty of room for additional debt; the company reported $158.1 million in long-term debt and another $75.9 million in short-term debt at the end of Q1. The unemployment rates in the company’s main service areas are something of a mixed bag at present. While the rates in Delaware, Maryland, and Florida have all declined since FY 2010 (and those in the first two were never that high to begin with – see figure), Florida’s rate has lagged behind the U.S. average since last year. Delaware’s rate also increased recently for the first time since the beginning of 2013. A brighter picture is presented by economic growth in the service areas, however. GDP growth has increased in all three states since the beginning of 2013 (see second figure), while that of Florida, which is an increasingly important contributor to Chesapeake’s earnings, almost reached 5%. Furthermore, population growth in Florida shows few signs of slowing as Baby Boomers reach retirement age and move south. Very recent changes to the unemployment rate aside, then, Chesapeake’s service area economies should support continued earnings growth so long as the company continues to make the investments necessary to meet increased demand. Delaware Unemployment Rate data by YCharts Delaware Change in GDP data by YCharts Florida can also be expected to provide a short-term earnings boost this winter due to the presence of El Niño, which is expected to make its strongest appearance in the last 50 years . The event has historically been associated with much colder-than-average winter temperatures in Florida, especially during Q1 . We are talking about Florida, of course, so even very cold temperatures compared to the long-term average will result in a smaller increase to natural gas demand than even a smaller average temperature reduction in Delaware or Maryland would. Florida’s contribution to the company’s total heating degree days in recent years has not be inconsequential, however, and El Niño can be expected to have a positive impact on its earnings as a result, albeit not a major one. Valuation The analyst earnings estimates for Chesapeake Utilities in FY 2015 and FY 2016 have increased substantially in response to its better-than-expected Q1 results and continued investment in high-demand areas. The FY 2015 consensus estimate has increased from $2.54 to $2.77 over the last 90 days, while the FY 2016 estimate has increased from $2.72 to $2.82 over the same period. The achievement of both estimates would push the company’s streak of record annual earnings to ten, while also representing double-digit earnings growth. Based on a share price of $54.51 at the time of this writing, the company’s shares trade at 18.3x trailing earnings and 19.7x and 19.3x forward earnings for FY 2015 and FY 2016, respectively. These valuations are very high, both relative to other electric and natural gas utilities and the company’s own respective 5-year ranges (see figure). The company’s shares are overvalued at this time, although I would not categorize them as very overvalued due to its large future earnings growth prospects. Potential investors should note that the company’s emphasis on earnings growth rather than dividend growth has resulted in a substantial degree of share price volatility over the years, providing more opportunities to buy during a downturn than is common in the broader utilities sector. CPK PE Ratio (TTM) data by YCharts Conclusion Chesapeake Utilities has managed to achieve very impressive earnings growth over the last decade by opting to fund growth via investments in high-demand utility service areas and unregulated acquisitions, rather than distributing the majority of its net income to investors. While this focus has left it with one of the less attractive dividends in the sector, it has also enabled the company to create a virtuous earnings cycle as it continues to increase its capital expenditures in growth areas. The company’s expanding footprint in Florida will provide its earnings with both short-term support resulting from an expected cold winter, as well as long-term support due to that state’s expanding population and economy. I do not recommend that potential investors initiate long investments in Chesapeake Utilities at this time, but that’s only because its shares are overvalued relative to future earnings growth. That said, the company’s share price has a history of volatility, and potential investors should be prepared to move quickly in the event that its shares become attractively valued. A move below $45, or 16x FY 2016 earnings, would make for such an opportunity. While this wouldn’t result in undervalued shares, the company’s potential earnings growth mitigates the need for a substantial margin of safety. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

4 Healthcare ETFs To Buy As Johnson & Johnson Beats Estimates

Original Post With the Q2 earnings season kicking off, Johnson & Johnson (NYSE: JNJ ) is the first to have reported earnings in the healthcare space. The world’s biggest maker of healthcare products continued its long streak of earnings beat despite currency headwinds and revenues that came in above our estimates. Further, the company lifted its full year outlook, reflecting confidence in its future growth. Johnson & Johnson Q2 Results in Focus Earnings per share came in at $1.71, a couple of cents above the Zacks Consensus Estimate but 3.9% below the year-ago earnings. Revenues slid 8.8% year over year to $17.8 billion but edged past the Zacks Consensus Estimate of $17.7 billion. Healthy sales of new drugs including Zytiga, Invokana, Imbruvica, and Xarelto and strength of old drugs such as Stelara, Concerta, Simponi and Invega Sustenna offset a steep decline in sales of the hepatitis C medicine – Olysio – which has lost its competitive position in the U.S. to its rivals Gilead (NASDAQ: GILD ) and AbbVie (NYSE: ABBV ). In spite of the fact that a strong U.S. dollar would remain a major drag on international revenue growth, the company raised its earnings per share guidance to $6.10-$6.20 from $6.04-$6.19. The new midpoint is above the current Zacks Consensus Estimate of $6.14. Market Impact Despite the earnings beat and encouraging guidance, shares of JNJ dropped as much as 1.7% on the day but recovered slightly to close at down 0.5%. This could be an attractive entry point for value investors given that Johnson & Johnson has a solid Value Style Score of ‘B’. Further, the stock has a favorable Zacks Rank #3 (Hold) and a solid industry Rank in the top 30% at the time of writing. ETFs to Buy That being said, investors could pile up some of the top ranked healthcare ETFs having the largest allocation to this behemoth for higher returns. We have detailed four of them below. All of them have a Zacks ETF Rank of 2 or ‘Buy’ rating, suggesting that they will outperform the market in the coming months. Health Care Select Sector SPDR ETF (NYSEARCA: XLV ) The most popular healthcare ETF, XLV follows the S&P Health Care Select Sector Index. This fund manages about $15.4 billion in its asset base and trades in heavy volume of more than 9.2 million shares. Expense ratio came in at 0.15% annually. In total, the fund holds 56 securities in its basket with JNJ taking the top spot at 9.51% of the assets. Pharma accounts for 42.9% share from a sector look while biotech, healthcare providers and services, and equipment and supplies make up for a double-digit exposure each. The fund has gained about 11.7% in the year to date time frame. iShares U.S. Healthcare ETF (NYSEARCA: IYH ) This fund provides exposure to 106 securities by tracking the Dow Jones U.S. Health Care Index. Here again, Johnson & Johnson dominates the fund’s return at 9.11% of total assets. In terms of industrial exposure, pharma takes the top spot at 41%, followed by biotech (23.2%), healthcare providers & services (16.3%) and healthcare equipment & supplies (15.2%). The product has amassed nearly $2.6 billion in its asset base while it charges 44 bps in annual fees. It trades in good volume of more than 23,000 shares a day and is up 13.8% this year. iShares U.S. Pharmaceuticals ETF (NYSEARCA: IHE ) This ETF targets the pharma corner of the broad healthcare space and tracks the Dow Jones U.S. Select Pharmaceuticals Index. Holding 39 stocks in its basket, Johnson & Johnson occupies the top position at 9.11%. Pharma takes the largest share at 85.7% while biotech takes the remainder. The product has managed nearly $1.2 billion in its asset base while volume is relatively light at under 56,000 shares a day on average. The fund charges 444 bps in fees per year from investors and has surged 20.9% so far this year. Vanguard Health Care ETF (NYSEARCA: VHT ) This ETF tracks the MSCI US Investable Market Health Care 25/50 Index and holds 349 stocks in its basket. Out of these, Johnson & Johnson takes the top spot with a 7.9% allocation. Pharma takes the largest share at 36.8% while biotech and healthcare equipment round off the top three spots. VHT is also one of the popular and liquid ETFs with AUM of $6.2 billion and average daily volume of over 297,000 shares. It charges 12 bps in annual fees and expenses. The product has added 13.6% in the year to date time frame.